Haemophilus Influenzae (Hib) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine
Conditions: Haemophilus Influenzae Type b; Neisseria MeningitidisIntervention: Biological: Haemophilus influenzae type b- and meningococcal (vaccine)Sponsor: GlaxoSmithKlineCompleted - verified November 2011 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2005 Category: Research Source Type: clinical trials
